Latest News in the pharma Industry

Policy & Regulation

Merck Statement on FDA Advisory Committee for GRASTEK (Timothy Grass Pollen Allergen Extract)

Merck Statement on FDA Advisory Committee for GRASTEK (Timothy Grass Pollen Allergen Extract)

13 Dec 2013

Read more 
FDA Advisory Committee Votes on Investigational Medicine Metreleptin

FDA Advisory Committee Votes on Investigational Medicine Metreleptin

12 Dec 2013

Read more 
ICH Reviews Future ICH Topics and its Organisation

ICH Reviews Future ICH Topics and its Organisation

11 Dec 2013

Read more 
China Finally Allows FDA To Add Inspectors

China Finally Allows FDA To Add Inspectors

9 Dec 2013

Read more 
Risk Assessment for Ascertaining GMP for Excipients

Risk Assessment for Ascertaining GMP for Excipients

5 Dec 2013

Read more 
Rx-360 Applauds Passage of Drug Quality and Security Act

Rx-360 Applauds Passage of Drug Quality and Security Act

29 Nov 2013

Read more 
FDA Warning Letter Statistics 2013 Regarding Process Validation/Qualification/Calibration

FDA Warning Letter Statistics 2013 Regarding Process Validation/Qualification/Calibration

28 Nov 2013

Read more 
FDA Approves Merck’s NOXAFIL (posaconazole) Delayed-Release Tablets

FDA Approves Merck’s NOXAFIL (posaconazole) Delayed-Release Tablets

27 Nov 2013

Read more 
Xigduo (Dapagliflozin and Metformin Hydrochloride) Receives Positive CHMP Opinion in the EU for the Treatment of Type 2 Diabetes

Xigduo (Dapagliflozin and Metformin Hydrochloride) Receives Positive CHMP Opinion in the EU for the Treatment of Type 2 Diabetes

27 Nov 2013

Read more 
FDA Approves NEXAVAR (Sorafenib)

FDA Approves NEXAVAR (Sorafenib)

25 Nov 2013

Read more 
CHMP Determines Dimethyl Fumarate in TECFIDERA to be a New Active Substance in the EU

CHMP Determines Dimethyl Fumarate in TECFIDERA to be a New Active Substance in the EU

25 Nov 2013

Read more 
FDA Grants Regular Approval for Crizotinib

FDA Grants Regular Approval for Crizotinib

22 Nov 2013

Read more